Who invested in Pyxis Oncology

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 2 months ago

Funding summaryUpdated 26 Oct 2026

$110Mraised across 1 round since 2026, from 1 source

Latest round: Round, $110MSept 2026
Investors: 5

See who backed them

The rounds

Sept 2026
Round$110M
Source recorded

Founders and team

From Pyxis Oncology's own website and the SEC filings it signed: 5 on the team.

Coming SoonChief Executive Officer and Chairman of the Board
Michael A. MetzgerDirector
John FlavinLead Independent Director
Lara SullivanExecutive Officer, Directori
Robert CraneExecutive Officeri

On the board, as filediChristian SchetterChristopher O'DonnellDavid SteinbergGotham MakkerLucio Iannone

Everyone who backed them

RA Capital ManagementPrivate equity1round

Perceptive AdvisorsAsset manager1round

Janus Henderson InvestorsPrivate equity1round

RTW Investments LLCGrowth equity1round

Blue OwlAsset manager1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Pyxis Oncology as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

SynergenicsVenture studioPer its own site

Quick answers about Pyxis Oncology

Who invested in Pyxis Oncology?

Pyxis Oncology's investors include RA Capital Management, Perceptive Advisors, Janus Henderson Investors, RTW Investments LLC and Blue Owl.

How much has Pyxis Oncology raised?

Pyxis Oncology has raised $110M across 1 round since 2026.

When did Pyxis Oncology last raise?

Pyxis Oncology's most recent round was an Undisclosed round of $110M in Sept 2026.

What was Pyxis Oncology's biggest round?

Its most recent round, $110M in Sept 2026, is also its largest on record.

Who backed Pyxis Oncology first?

Pyxis Oncology's first round on record, in Sept 2026, was backed by RA Capital Management, Perceptive Advisors and Janus Henderson Investors and 2 others.